| study to evaluate new potential effect of Natural Products (Hydrogel) in treatment of refractive cases of Candida albicans as an add on therapy (product development) | Life Sciences & Biotechnology | 2024 | 2026 |
| Evaluation of safety and efficacy of intradermal administration of vaccines using indigenous microneedles: A pre-clinical study in mice, followed by clinical study in human beings. | Life Sciences & Biotechnology | 2023 | 2026 |
| To explore the role of CD146 and Heat shock proteins in patients with Idiopathic Intracranial hypertension (IIH) and to correlate them with disease severity and with associated sleep and circadian rhythm disruption. | Life Sciences & Biotechnology | 2023 | 2026 |
| Human Herpesvirus-6 (HHV-6) in infertility: causative agent or innocent bystander? | Life Sciences & Biotechnology | 2023 | 2026 |
| To evaluate the effect of IGF-1 analogue and NMDAR antagonist in rat model of infantile spasm: A synergistic approach to reduce the excitotoxicity | Life Sciences & Biotechnology | 2024 | 2027 |
| Establishing novel peripheral-central auditory neurogenic niches for understanding cochlear regeneration and genetic basis of communication outcomes in cochlear implantees | Life Sciences & Biotechnology | 2023 | 2026 |
| Genetic Characterization of UBA1 Mutation-Negative VEXAs-like syndrome Patients by Targeted Next Generation sequencing Approach | Life Sciences & Biotechnology | 2024 | 2026 |
| Universal testing of germline variants in cases of acute myeloid leukemia and myelodysplastic syndrome and to study the role of somatic variants in their pathogenesis | Life Sciences & Biotechnology | 2023 | 2026 |
| Elucidation of Mycobacterium leprae -derived cell-free DNA (cfDNA) for diagnosis of leprosy | Life Sciences & Biotechnology | 2023 | 2025 |
| Investigation on integrated cellular and genomic interplay of host-pathogen interaction in isolated renal mucormycosis | Life Sciences & Biotechnology | 2024 | 2027 |